| Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 A Bonaventura, A Vecchié, L Dagna, K Martinod, DL Dixon, ... Nature Reviews Immunology 21 (5), 319-329, 2021 | 759 | 2021 |
| Obesity phenotypes and their paradoxical association with cardiovascular diseases A Vecchié, F Dallegri, F Carbone, A Bonaventura, L Liberale, ... European journal of internal medicine 48, 6-17, 2018 | 297 | 2018 |
| Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review JG Chiabrando, A Bonaventura, A Vecchié, GF Wohlford, AG Mauro, ... Journal of the American College of Cardiology 75 (1), 76-92, 2020 | 283 | 2020 |
| Update on inflammatory biomarkers and treatments in ischemic stroke A Bonaventura, L Liberale, A Vecchié, M Casula, F Carbone, F Dallegri, ... International journal of molecular sciences 17 (12), 1967, 2016 | 178 | 2016 |
| Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial R Caricchio, A Abbate, I Gordeev, J Meng, PY Hsue, T Neogi, R Arduino, ... Jama 326 (3), 230-239, 2021 | 159 | 2021 |
| Adipocytokine levels in obese and non-obese subjects: an observational study G Derosa, E Fogari, A D’Angelo, L Bianchi, A Bonaventura, D Romano, ... Inflammation 36, 914-920, 2013 | 151 | 2013 |
| Novel findings in neutrophil biology and their impact on cardiovascular disease A Bonaventura, F Montecucco, F Dallegri, F Carbone, TF Lüscher, ... Cardiovascular Research 115 (8), 1266-1285, 2019 | 139 | 2019 |
| Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies A Bonaventura, A Vecchie, TS Wang, E Lee, PC Cremer, B Carey, ... Frontiers in immunology 11, 1625, 2020 | 136 | 2020 |
| The role of inflammation in cardiovascular outcome F Montecucco, L Liberale, A Bonaventura, A Vecchiè, F Dallegri, ... Current atherosclerosis reports 19, 1-9, 2017 | 132 | 2017 |
| Inflammasome formation in the lungs of patients with fatal COVID-19 S Toldo, R Bussani, V Nuzzi, A Bonaventura, AG Mauro, A Cannatà, ... Inflammation Research 70, 7-10, 2021 | 126 | 2021 |
| The pathophysiological role of neutrophil extracellular traps in inflammatory diseases A Bonaventura, L Liberale, F Carbone, A Vecchié, C Diaz-Cañestro, ... Thrombosis and haemostasis 118 (01), 006-027, 2018 | 125 | 2018 |
| Cellular recruitment in myocardial ischaemia/reperfusion injury A Bonaventura, F Montecucco, F Dallegri European Journal of Clinical Investigation 46 (6), 590-601, 2016 | 122 | 2016 |
| Neutrophil extracellular traps and cardiovascular diseases: an update A Bonaventura, A Vecchié, A Abbate, F Montecucco Cells 9 (1), 231, 2020 | 118 | 2020 |
| Effects of berberine on lipid profile in subjects with low cardiovascular risk G Derosa, A D'Angelo, A Bonaventura, L Bianchi, D Romano, P Maffioli Expert opinion on biological therapy 13 (4), 475-482, 2013 | 115 | 2013 |
| Regulation and function of extracellular nicotinamide phosphoribosyltransferase/visfatin F Carbone, L Liberale, A Bonaventura, A Vecchiè, M Casula, M Cea, ... Comprehensive Physiology 7 (2), 603-621, 2011 | 109 | 2011 |
| IL‐18 and infections: Is there a role for targeted therapies? A Vecchie, A Bonaventura, S Toldo, L Dagna, CA Dinarello, A Abbate Journal of cellular physiology 236 (3), 1638-1657, 2021 | 105 | 2021 |
| The role of adipocytokines in coronary atherosclerosis L Liberale, A Bonaventura, A Vecchiè, C Matteo, F Dallegri, F Montecucco, ... Current atherosclerosis reports 19, 1-12, 2017 | 97 | 2017 |
| Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients G Derosa, A Carbone, I Franzetti, F Querci, E Fogari, L Bianchi, ... Diabetes research and clinical practice 98 (1), 51-60, 2012 | 92 | 2012 |
| The role of IL-6 and IL-6 blockade in COVID-19 N Potere, A Batticciotto, A Vecchié, E Porreca, A Cappelli, A Abbate, ... Expert review of clinical immunology 17 (6), 601-618, 2021 | 91 | 2021 |
| Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases M Casula, F Montecucco, A Bonaventura, L Liberale, A Vecchié, ... Vascular pharmacology 99, 1-12, 2017 | 88 | 2017 |
